Doctors Note Logo

Published on: 9/13/2026

Can fluoxetine cause suicidal thoughts and when should I call my doctor?

Yes, fluoxetine (Prozac) carries an FDA boxed warning because it can increase suicidal thoughts and behaviors, most often in children, teens, and adults under 25, and usually within the first few weeks of starting treatment or after a dose change. Call your doctor right away if you notice new or worsening suicidal thoughts, self-harm urges, severe agitation, panic, aggression, impulsivity, insomnia, or an unusually elevated mood, and seek emergency care or call or text 988 if you feel unsafe now. Other urgent reasons to call include signs of serotonin syndrome, such as confusion, rapid heartbeat, fever, muscle stiffness, or tremor, plus unusual bleeding or a rash. Never stop fluoxetine abruptly on your own, since tapering decisions and monitoring schedules depend on your age, diagnosis, and other medications. There are several important factors and warning signs to weigh, so see below to understand more.

Because these symptoms can overlap with worsening depression, medication side effects, or another condition entirely, it helps to organize what you are feeling before you pick up the phone. A free, instant, online symptom check can help you clarify your symptoms, understand possible causes, and see which next steps and level of care make the most sense right now.

Last reviewed for medical accuracy: 09/12/2026

answer background

Explanation

Can Fluoxetine Cause Suicidal Thoughts and When Should I Call My Doctor?

Fluoxetine is a widely prescribed antidepressant in the selective serotonin reuptake inhibitor (SSRI) class. It’s commonly used to treat major depressive disorder, obsessive-compulsive disorder, bulimia nervosa, panic disorder and other conditions. While fluoxetine can be highly effective, it carries a boxed warning about an increased risk of suicidal thoughts and behaviors, especially in certain age groups. Understanding these risks and knowing when to seek medical help can keep you—or someone you care for—safe.

How Fluoxetine Works

  • Fluoxetine helps increase serotonin levels in the brain by preventing its reuptake into nerve cells.
  • Elevated serotonin can improve mood, reduce anxiety and ease obsessive thinking.
  • Therapeutic effects often appear after 4–6 weeks of continuous treatment, though some people feel benefits sooner.

The FDA Boxed Warning on Suicidal Thoughts

Regulatory agencies require all antidepressants, including fluoxetine, to carry a warning that in some users, particularly younger people, treatment may trigger or worsen suicidal thoughts.

  • Age groups at highest risk
    • Children (under 18)
    • Adolescents (18–24)
  • Risk window
    • Generally during the first 1–2 months of treatment
    • When doses are increased or decreased
  • Older adults (over 24)
    • Large studies have not shown a significant increase in suicidal thoughts in patients over 24
    • In adults over 65, fluoxetine may actually lower suicide risk by relieving depression

Why Suicidal Thoughts May Emerge

  1. Activation Side Effects
    • Restlessness, irritability or agitation may appear before mood improvement
    • Physical energy can increase before emotional recovery, giving a person the means to act on suicidal ideas
  2. Unmasking Underlying Thoughts
    • As depression lifts, individuals may become more aware of dark thoughts that pre-existed
  3. Dose Adjustments
    • Sudden changes in blood levels of fluoxetine can destabilize mood

Signs and Symptoms to Monitor

If you or someone you care for is taking fluoxetine, watch for any new or worsening behaviors. Key warning signs include:

  • New or intensified thoughts of self-harm or suicide
  • Increased anxiety, agitation or restlessness
  • Panic attacks or severe insomnia
  • Sudden mood swings or feelings of worthlessness
  • Aggressive or impulsive behavior
  • Withdrawal from social activities or routine tasks
  • Unexpected changes in appetite or energy levels

Keep a daily journal of mood and behavior changes—this can help your doctor track patterns and make timely decisions about your treatment.

When to Call Your Doctor

Contact your prescribing physician or a mental health professional if you notice:

  • Any increase in suicidal thoughts or self-harm behaviors
  • Rapid worsening of depression or anxiety symptoms
  • Intense restlessness or agitation that you can’t control
  • New panic attacks or worsening of existing ones
  • Severe sleep disturbances (inability to sleep or sleeping too much)
  • Sudden outbursts of anger or aggression
  • Any alarming changes in behavior, mood or physical health

If you suspect that you or someone else may act on suicidal thoughts or if life-threatening symptoms occur, do not wait. Call emergency services (for example, 911 in the U.S.) or go to the nearest emergency department.

Tips to Reduce Risk While on Fluoxetine

  • Schedule regular follow-up visits during the first two months of treatment.
  • Ask a trusted friend or family member to check in daily.
  • Avoid alcohol and recreational drugs—they can worsen depression and counteract medication.
  • Keep a consistent medication schedule; don’t skip doses or stop abruptly.
  • Report any side effects to your doctor right away—small dose adjustments can make a big difference.

For additional peace of mind, consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.

Balancing Benefits and Risks

Fluoxetine has helped millions of people reclaim their lives from depression and other psychiatric conditions. Most users tolerate it well, and only a small percentage experience severe side effects or suicidal thinking. Still, staying informed and vigilant during the early weeks of treatment is crucial.

Other Resources

  • Your prescribing doctor or psychiatrist is your best source for personal medical advice.
  • A mental health counselor or therapist can provide strategies to cope with emerging distress.
  • Local or national suicide prevention hotlines are available 24/7 if you need immediate emotional support.

Speak to a Doctor

Never hesitate to reach out to a healthcare professional about any serious or life-threatening symptoms. If you or someone you know experiences suicidal thoughts or behaviors in association with fluoxetine—or for any other reason—seek medical help immediately.


This information is based on current medical guidelines and reputable sources. Always follow your doctor’s instructions and report any concerning symptoms without delay.

(References)

  • * Finnegan KT, Gabiola JM. Fluoxetine overdose. Am J Psychiatry. 1988 Dec;145(12):1604. doi: 10.1176/ajp.145.12.1604b. PMID: 3264119.

  • * Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ. 1995 Jan 28;310(6974):215-8. doi: 10.1136/bmj.310.6974.215. PMID: 7677826; PMCID: PMC2548617.

  • * Leroi I, Walentynowicz MA. Fluoxetine-imipramine interaction. Can J Psychiatry. 1996 Jun;41(5):318-9. doi: 10.1177/070674379604100515. PMID: 8793156.

  • * Hammad TA, Laughren T, Racoosin J. Suicidality in pediatric patients treated with antidepressant drugs. Arch Gen Psychiatry. 2006 Mar;63(3):332-9. doi: 10.1001/archpsyc.63.3.332. PMID: 16520440.

  • * March JS, Silva S, Petrycki S, Curry J, Wells K, Fairbank J, Burns B, Domino M, McNulty S, Vitiello B, Severe J. The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry. 2007 Oct;64(10):1132-43. doi: 10.1001/archpsyc.64.10.1132. PMID: 17909125.

  • * Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, Li X, Cuijpers P, Coghill D, Xiang Y, Hetrick SE, Leucht S, Qin M, Barth J, Ravindran AV, Yang L, Curry J, Fan L, Silva SG, Cipriani A, Xie P. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020 Jul;7(7):581-601. doi: 10.1016/S2215-0366(20)30137-1. PMID: 32563306; PMCID: PMC7303954.

  • * Boaden K, Tomlinson A, Cortese S, Cipriani A. Antidepressants in Children and Adolescents: Meta-Review of Efficacy, Tolerability and Suicidality in Acute Treatment. Front Psychiatry. 2020;11:717. doi: 10.3389/fpsyt.2020.00717. Epub 2020 Sep 2. PMID: 32982805; PMCID: PMC7493620.

  • * Hetrick SE, McKenzie JE, Bailey AP, Sharma V, Moller CI, Badcock PB, Cox GR, Merry SN, Meader N. New generation antidepressants for depression in children and adolescents: a network meta-analysis. Cochrane Database Syst Rev. 2021 May 24;5(5):CD013674. doi: 10.1002/14651858.CD013674.pub2. Epub 2021 May 24. PMID: 34029378; PMCID: PMC8143444.

  • * Attia E, Walsh BT. Eating Disorders: A Review. JAMA. 2025 Apr 8;333(14):1242-1252. doi: 10.1001/jama.2025.0132. PMID: 40048192.

  • * Del Casale A, Spirito S, Arena JF, Preissner S, Borro M, Gentile G, Modesti MN, Preissner R, Ferracuti S, Simmaco M. Esketamine Combined With SSRI or SNRI for Treatment-Resistant Depression. JAMA Psychiatry. 2025 Aug 1;82(8):810-817. doi: 10.1001/jamapsychiatry.2025.0200. PMID: 40172868; PMCID: PMC11966478.

Thinking about asking ChatGPT?Ask me instead

Tell your friends about us.

We would love to help them too.

smily Shiba-inu looking

For First Time Users

What is Ubie’s Doctor’s Note?

We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.

Was this page helpful?

Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.